CID 122541471

Schembl18078012

Structural Information

Molecular Formula
C15H16N6O5
SMILES
CC([C@@H](C(=O)O)NC(=O)N[C@@H](CC#C)C1=NC(=NO1)C2=NC=CN=C2)O
InChI
InChI=1S/C15H16N6O5/c1-3-4-9(18-15(25)19-11(8(2)22)14(23)24)13-20-12(21-26-13)10-7-16-5-6-17-10/h1,5-9,11,22H,4H2,2H3,(H,23,24)(H2,18,19,25)/t8?,9-,11-/m0/s1
InChIKey
DGLNBPSKIUYJIJ-PCFYAGROSA-N
Compound name
(2S)-3-hydroxy-2-[[(1S)-1-(3-pyrazin-2-yl-1,2,4-oxadiazol-5-yl)but-3-ynyl]carbamoylamino]butanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

2
Patents

360.11823 Da
Monoisotopic Mass

-1.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 361.12551 179.9
[M+Na]+ 383.10745 183.9
[M-H]- 359.11095 176.3
[M+NH4]+ 378.15205 182.7
[M+K]+ 399.08139 182.7
[M+H-H2O]+ 343.11549 162.3
[M+HCOO]- 405.11643 188.1
[M+CH3COO]- 419.13208 218.3
[M+Na-2H]- 381.09290 178.3
[M]+ 360.11768 173.2
[M]- 360.11878 173.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe